ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Desmopressin diacetate
C50H72N14O16S2
1189.3 g/mol
APIWarning

Desmopressin diacetate

CAS16789-98-3
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Desmopressin diacetate is a salt form of desmopressin, a synthetic peptide analog of the natural hormone arginine vasopressin. It is primarily used as an active pharmaceutical ingredient in the manufacture of prescription medicines.

active pharmaceutical ingredient in prescription drug manufacturing

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Desmopressin diacetate?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongSame Parent

Desmopressin acetate trihydrate

CAS62357-86-2

pharmaceutical raw material

StrongSame Parent

Desmopressin

CAS16679-58-6

pharmaceutical raw material

StrongStructure SimilarSimilarity 0.88

Arginine vasopressin

CAS113-79-1

pharmaceutical raw material

ReferenceSame Category

Flibanserin

CAS167933-07-5

pharmaceutical raw material

ReferenceSame Category

(Z)-N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-4-(dimethylamino)but-2-enamide

CAS1680184-59-1

pharmaceutical raw material

ReferenceSame Category

Rimonabant

CAS168273-06-1

pharmaceutical raw material

ReferenceSame Category

Oxymatrine

CAS16837-52-8

active pharmaceutical ingredient

Referencestereoisomer of

Desmopressin acetate

CAS62288-83-9

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Warning
H332Harmful if inhaled
Identifiers
IUPAC Name

acetic acid;(2S)-N-[(2R)-1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide

InChIKey

GNASTRMPURYAFJ-VCCVNBJCSA-N

SMILES

CC(=O)O.CC(=O)O.C1C[C@H](N(C1)C(=O)[C@@H]2CSSCCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N

Synonyms (9)
  • Desmopressin diacetate
  • Desmopressin monoacetate

Sourcing Desmopressin diacetate?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→